Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cell Transformation, Neoplastic

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cell Transformation, Neoplastic in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19902 (20.00)18.7374
1990's3 (30.00)18.2507
2000's2 (20.00)29.6817
2010's3 (30.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anandi, VL; Ashiq, KA; Lahiri, M; Nitheesh, K1
DaSilva, SC; Konger, RL; Kozman, AA; Martel, KC; Rezania, S; Sahu, RP; Travers, JB; Warren, SJ; Yao, Y1
Berman, B; Cockerell, CJ1
Podolak-Dawidziak, M1
Karpatkin, S; Pearlstein, E; Salk, PL; Yogeeswaran, G1
Bussolino, F; Camussi, G; Ghezzo, F; Pegoraro, L1
Bennett, SA; Birnboim, HC1
Bennett, SA; Birnboim, HC; Leite, LC1
Kume, K; Shimizu, T1
Baldi, E; Bonaccorsi, L; Cioppi, F; Forti, G; Granchi, S; Luconi, M; Maggi, M; Miele, L; Mini, E; Muratori, M; Peri, A; Pesciullesi, A; Serio, M1

Reviews

1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cell Transformation, Neoplastic

ArticleYear
[Role of white cells and neoplastic cells in haemostasis].
    Polskie Archiwum Medycyny Wewnetrznej, 2002, Volume: 107, Issue:5

    Topics: Cell Transformation, Neoplastic; Hemostasis; Humans; Leukocytes; Neoplasms; Platelet Activating Factor; Transforming Growth Factors

2002

Other Studies

9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cell Transformation, Neoplastic

ArticleYear
Platelet-activating factor promotes motility in breast cancer cells and disrupts non-transformed breast acinar structures.
    Oncology reports, 2016, Volume: 35, Issue:1

    Topics: Breast Neoplasms; Cell Culture Techniques; Cell Line; Cell Movement; Cell Transformation, Neoplastic; Female; Humans; MAP Kinase Kinase 4; Neoplasm Metastasis; Phosphatidylinositol 3-Kinases; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction

2016
Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.
    Carcinogenesis, 2012, Volume: 33, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate

2012
Pathobiology of actinic keratosis: ultraviolet-dependent keratinocyte proliferation.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:1 Suppl 1

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Proliferation; Cell Transformation, Neoplastic; DNA; fas Receptor; Humans; Immune Tolerance; Inflammation; Keratinocytes; Keratosis, Actinic; Platelet Activating Factor; Signal Transduction; Skin; Skin Neoplasms; Sunlight; T-Lymphocytes, Regulatory; Tumor Suppressor Protein p53; Ultraviolet Rays; Urocanic Acid

2013
Role of platelets in tumor cell metastases.
    Annals of the New York Academy of Sciences, 1981, Volume: 370

    Topics: Animals; Blood Coagulation Factors; Blood Platelets; Cell Line; Cell Transformation, Neoplastic; Centrifugation; Drug Synergism; Fibroblasts; Hot Temperature; Isoflurophate; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred WF; Serotonin; Trypsin

1981
Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation.
    Blood, 1982, Volume: 59, Issue:1

    Topics: Cell Line; Cell Transformation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Leukocytes; Lysophosphatidylcholines; Macrophages; Platelet Activating Factor; Receptors, Complement; Tetradecanoylphorbol Acetate

1982
Platelet activating factor induces transformation of human fibroblasts.
    Advances in prostaglandin, thromboxane, and leukotriene research, 1995, Volume: 23

    Topics: Alkaloids; Analysis of Variance; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; Fibroblasts; Genistein; Growth Inhibitors; Humans; Indomethacin; Infant, Newborn; Isoflavones; Phospholipid Ethers; Platelet Activating Factor; Protein Kinase C; Skin; Staurosporine

1995
Platelet activating factor, an endogenous mediator of inflammation, induces phenotypic transformation of rat embryo cells.
    Carcinogenesis, 1993, Volume: 14, Issue:7

    Topics: Animals; Cell Transformation, Neoplastic; Cells, Cultured; Culture Media; Embryo, Mammalian; Inflammation; Phenotype; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled

1993
Platelet-activating factor (PAF) induces growth stimulation, inhibition, and suppression of oncogenic transformation in NRK cells overexpressing the PAF receptor.
    The Journal of biological chemistry, 1997, Sep-05, Volume: 272, Issue:36

    Topics: Animals; Cell Adhesion; Cell Cycle; Cell Division; Cell Line; Cell Transformation, Neoplastic; Cyclin D1; Cyclins; Gene Expression Regulation; Genes, Immediate-Early; Oncogene Proteins; Pertussis Toxin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Virulence Factors, Bordetella

1997
Uteroglobin reverts the transformed phenotype in the endometrial adenocarcinoma cell line HEC-1A by disrupting the metabolic pathways generating platelet-activating factor.
    International journal of cancer, 2000, Nov-15, Volume: 88, Issue:4

    Topics: Acetyltransferases; Adenocarcinoma; Arachidonic Acid; Cell Cycle; Cell Division; Cell Membrane; Cell Transformation, Neoplastic; Endometrial Neoplasms; Female; Humans; Kinetics; Phospholipases A; Platelet Activating Factor; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Transfection; Tumor Cells, Cultured; Uteroglobin

2000